News and Trends 1 Jun 2016
CRISPR Thx’ Founder: “We have over $250M in the bank”
So begins our series of videos documenting our biotech conference premier – Labiotech Refresh. Here Philip spoke with Rodger Novak, the CEO and founder of CRISPR Therapeutics, which is leading the biotech front on Gene Editing in Europe. Having the CEO of CRISPR Therapeutics come and speak at our first event was really exciting for […]